DLL4 and neoplasm: In our experimental setting, we did not observe single agent anti-tumor activity for the selective targeting of human, tumor cell-expressed Dll4 or anti-tumor additivity for the concomitant blocking of human (tumor cells) and murine (endothelial cells) Dll4.